Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Due to Alzheimer's Disease (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06792877
What this trial is testing

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more
VA Boston Healthcare System 100
Very early researchActive Not RecruitingNCT04075435
What this trial is testing

Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseAnxietyAgitation,Psychomotor+1 more
Mclean Hospital 12
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Not applicableUnknownNCT03672279
What this trial is testing

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease

Who this might be right for
Dementia AlzheimersMild Cognitive ImpairmentCognition Disorders+1 more
University Hospital, Basel, Switzerland 100
Not applicableStudy completedNCT06151808
What this trial is testing

Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects

Who this might be right for
Alzheimer Disease
Sinotau Pharmaceutical Group 42
Testing effectiveness (Phase 2)Ended earlyNCT02322021
What this trial is testing

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer Type
Eisai Inc. 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612150
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of TML-6 in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Merry Life Biomedical Co., Ltd. 210
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951
What this trial is testing

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia ModerateDementia, MildAlzheimer Disease
Actinogen Medical 247
Post-approval studies (Phase 4)Study completedNCT02553928
What this trial is testing

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Who this might be right for
Alzheimer Dementia (AD)
H. Lundbeck A/S 62
Testing effectiveness (Phase 2)Study completedNCT05227820
What this trial is testing

Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia

Who this might be right for
Alzheimer Disease
Neurological Associates of West Los Angeles 23
Testing effectiveness (Phase 2)Study completedNCT05104463
What this trial is testing

CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentDementia
CuraSen Therapeutics, Inc. 64
Early research (Phase 1)Not Yet RecruitingNCT07489599
What this trial is testing

QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease(AD)Mild Cognitive Impairment (MCI)
Qilu Pharmaceutical Co., Ltd. 68
Testing effectiveness (Phase 2)UnknownNCT03806478
What this trial is testing

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
DementiaAlzheimer Disease 1Alzheimer Disease 2+1 more
Aphios 60
Not applicableLooking for participantsNCT05997030
What this trial is testing

Low-Intensity Focused Ultrasound (LIFU) Neuromodulation

Who this might be right for
Alzheimer Disease
Ali Rezai 15
Testing effectiveness (Phase 2)Looking for participantsNCT07027072
What this trial is testing

Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild DementiaAlzheimer's Disease
NeuroBiogen Co., Ltd 114
Not applicableEnrolling By InvitationNCT06761066
What this trial is testing

Efficacy and Safety of NVP-NK4146 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Who this might be right for
Alzheimer Disease
NVP Healthcare 60
Testing effectiveness (Phase 2)Study completedNCT04602624
What this trial is testing

Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Dementia
Supernus Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)Looking for participantsNCT06850597
What this trial is testing

Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

Who this might be right for
MCIMCI-AD, Early Stage Alzheimer's DiseaseAlzheimer's Disease
Medical University of Lodz 30
Not applicableLooking for participantsNCT07786116
What this trial is testing

The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions

Who this might be right for
PARKINSON DISEASE (Disorder)ParkinsonParkinson Disease+19 more
University of Cambridge 215
Not applicableStudy completedNCT00735046
What this trial is testing

Cognitive Behavioural Therapy of Early Dementia

Who this might be right for
Dementia
Technical University of Munich 200
Next Page